351 related articles for article (PubMed ID: 33225930)
21. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
[TBL] [Abstract][Full Text] [Related]
22. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
Masaki Y; Ueda Y; Yanagisawa H; Arita K; Sakai T; Yamada K; Mizuta S; Fukushima T; Takai K; Aoki S; Kawabata H
Intern Med; 2023 Jan; 62(1):27-32. PubMed ID: 35598998
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
[TBL] [Abstract][Full Text] [Related]
24. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
[TBL] [Abstract][Full Text] [Related]
25. TAFRO Syndrome.
Igawa T; Sato Y
Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
[TBL] [Abstract][Full Text] [Related]
26. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
[TBL] [Abstract][Full Text] [Related]
27. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
[TBL] [Abstract][Full Text] [Related]
28. International definition of iMCD-TAFRO: future perspectives.
Nishimura Y; Nishimura MF; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):73-78. PubMed ID: 35474036
[TBL] [Abstract][Full Text] [Related]
29. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
30. A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.
Ohta T; Oda N; Saito K; Tamiya S; Ueno T
Cureus; 2020 Dec; 12(12):e12175. PubMed ID: 33489586
[TBL] [Abstract][Full Text] [Related]
31. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.
Tanaka M; Tsujimoto H; Yamamoto K; Shimoda S; Oka K; Takeoka H
Medicine (Baltimore); 2017 Oct; 96(40):e8216. PubMed ID: 28984775
[TBL] [Abstract][Full Text] [Related]
33. Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.
Tsurumi H; Fujigaki Y; Yamamoto T; Iino R; Taniguchi K; Nagura M; Arai S; Tamura Y; Ota T; Shibata S; Kondo F; Kurose N; Masaki Y; Uchida S
Intern Med; 2018 May; 57(10):1433-1438. PubMed ID: 29321413
[TBL] [Abstract][Full Text] [Related]
34. TAFRO syndrome: A disease that known is half cured.
Chen T; Feng C; Zhang X; Zhou J
Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
Hiramatsu S; Ohmura K; Tsuji H; Kawabata H; Kitano T; Sogabe A; Hashimoto M; Murakami K; Imura Y; Yukawa N; Yoshifuji H; Fujii T; Takaori-Kondo A; Mimori T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):64-71. PubMed ID: 27181237
[TBL] [Abstract][Full Text] [Related]
36. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
37. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.
José FF; Kerbauy LN; Perini GF; Blumenschein DI; Pasqualin DDC; Malheiros DMAC; Campos Neto GC; de Souza Santos FP; Piovesan R; Hamerschlak N
Medicine (Baltimore); 2017 Mar; 96(13):e6271. PubMed ID: 28353560
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D
Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382
[TBL] [Abstract][Full Text] [Related]
39. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
[TBL] [Abstract][Full Text] [Related]
40. Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.
Fujimoto S; Kawabata H; Kurose N; Kawanami-Iwao H; Sakai T; Kawanami T; Fujita Y; Fukushima T; Masaki Y
Medicine (Baltimore); 2017 Dec; 96(50):e9220. PubMed ID: 29390349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]